Screener
Bristol-Myers Squibb BMY EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on the most recent quarter.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's EV / EBITDA?
- Bristol-Myers Squibb (BMY) reported EV / EBITDA of 10.1× in Q2 2026.
- How has Bristol-Myers Squibb's EV / EBITDA changed year-over-year?
- Bristol-Myers Squibb's EV / EBITDA decreased by 1.6% year-over-year, from 10.3× to 10.1×.
- What is the long-term trend for Bristol-Myers Squibb's EV / EBITDA?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's EV / EBITDA has grown at a -26.1% compound annual growth rate (CAGR), from 49.7× to 11×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Bristol-Myers Squibb's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude